Chronic Coronary Disease Guideline E2: Risk Assessment and Lifestyle Factors
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Risk assessment is the foundation that treatment decisions are built upon. In this episode, Dr. Virani and Newby discuss the guideline's detailed recommendations when it comes to evaluation and risk assessment, including the encouragement to defer testing in certain patients due to its inherent risks and costs. They also go into the lifestyle factors that play an important role in managing CCD, including optimal nutrition and exercise. And they emphasize the guideline's recommendations on how to best counsel patients about drug and alcohol use.
Recommended Videos
Assessment of Insomnia in an Office Visit
Medications to Treat Insomnia
Diagnosing Medication Non-Adherence in Hypertension Treatment
Therapeutic Inertia and Medication Non-Adherence in Hypertension Treatment
What to do if an Incidental Cardiovascular Variant is Identified
Loading...
Save Video
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.